BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS
申请人:Pfizer Products Inc.
公开号:EP1272484A2
公开(公告)日:2003-01-08
US7119207B2
申请人:——
公开号:US7119207B2
公开(公告)日:2006-10-10
[EN] BENZOAMIDE PIPERIDINE CONTAINING COMPOUNDS AND RELATED COMPOUNDS<br/>[FR] COMPOSES CONTENANT BENZOAMIDE PIPERIDINE ET COMPOSES APPARENTES
申请人:PFIZER PROD INC
公开号:WO2001077100A2
公开(公告)日:2001-10-18
The present invention relates to certain benzoamide piperidine containing compounds of formula I and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders. (I)
Benzoamide piperidine containing compounds and related compounds
申请人:——
公开号:US20030087925A1
公开(公告)日:2003-05-08
The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.